The EBO and Euretina have come together to develop the FEBOS-R qualification.
The purpose of this qualification is to harmonise the standard of expected knowledge and clinical acumen for retina specialists across Europe.
The exam will assess candidates’ ability to manage a retina clinic. It could be seen as an “exit” exam, that someone has achieved a theoretical level of knowledge required to manage patients safely and effectively.
In this way, Euretina and the EBO are setting the standard for retina specialists and patient care across Europe.
This exam will be conducted in two distinct parts:
Candidates must pass Section I to proceed to Section II, the viva voce (clinical knowledge) test.
Each station interview will be based on two cases (one case per subject area) and will last 15 minutes. The stations are:
|Station||Subject 1||Subject 2|
|1||AMD / CSC||Imaging|
|2||Diabetes and Vascular Eye Diseases||Uveitis|
|3||Inherited Retinal Disease||Ocular Oncology (Tumours)|
Please note: these subjects represent the 8 subsections of Euretina. Each subject will carry an equivalent weight in the overall judgement of a candidate’s final score.
The following represent minimal requirements to sit the exam:
At a minimum, candidates should
Those with more extensive experience, but without a specific diploma will be considered.
Informal enquiries about eligibility can be made by emailing email@example.com. Please include “Exam Eligibility” in the subject line of your email so we can attend to it more quickly.
The examination working group will review applications to ensure applicants meet candidate requirements, prior to accessing the exam.
The EBO-Euretina exam has an introductory fee of €550.
Euretina will include a registration to the 23rd Euretina Congress in Amsterdam for those accepted to sit the exam.
Where an applicant is not accepted to sit the exam, they will be refunded €400. €150 is retained by EBO and Euretina to cover administration and document review costs.
Except in exceptional circumstances, if a candidate does not attend for the exam, or cancels after the closing date for applications, they will not be reimbursed their exam fee
Applications will open in December 2022. The application form will be accessed via a link on the EBO and Euretina websites.
Applications will close on March 14th 2023. EBO and Euretina reserve the right to close applications early if the number of expected applicants exceeds capacity.
During the application process, you will be asked to provide:
The Euretina Examination board will review applications. For those selected to become candidates:
If you do not pass PART I, you will be given an option:
Those who pass the EBO-Euretina exam will receive an EBO-accredited and stamped diploma, and be awarded the post-nominal title “FEBOS-R”
The minimum required knowledge is that covered in the AAO Basic and Clinical Sciences volumes:
Section 1: Update on General Medicine
Section 4: Ophthalmic Pathology and Intraocular Tumors
Section 9: Uveitis and Ocular Inflammation
Section 12: Retina and Vitreous (Please note a major revision of this volume has been published in 2022)
In addition, candidates will be expected to have kept abreast of recent important research, trials, and clinical practice.
The following have been recommended:
|AMD / CSC||
|Tumours||As well as the minimum required knowledge outlined above, candidates are expected to be aware of the latest research and trials in this area.
|VR|| As well as the minimum required knowledge outlined above, candidates are expected to be aware of the latest research and trials in this area.
|Diabetes & Vascular Diseases|| As well as the minimum required knowledge outlined above, candidates are expected to be aware of the latest research and trials in this area.
|Inherited Retinal Diseases||
Subscribe to our updates & instant alerts | Enter email below